Anavex Life Sciences Corp (AVXL)

[georgejjl]

Expect to achieve better than 50% enrollment by of before the start of Spring March 20, 2019 for the ANAVEX 2-73 Parkinson's Disease Dementia Trial in Spain

Since enrollment started on October 30, 2018 for the Phase 2 ANAVEX®2-73 Parkinson’s disease dementia (PDD) study, over one-third of the total patient enrollment target has been achieved as of February 7, 2019.

https://www.anavex.com/anavex-life-sciences-reports-fiscal-2019-first-quarter-financial-results-and-provides-clinical-study-updates/

Good luck and GOD bless,